Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...
“DESTINY-Breast11 results support T-DXd [plus] THP as a more effective and less toxic neoadjuvant treatment compared with ddAC-THP, and it may become the preferred regimen for patients with high-risk, ...
Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo ...
MedPage Today on MSN
'Remarkable' Survival Outcomes in Cisplatin-Ineligible Bladder Cancer
Event-free survival (EFS) improved by 60% and overall survival (OS) by 50% with the antibody-drug conjugate (ADC) enfortumab vedotin (Padcev) plus pembrolizumab (Keytruda) versus upfront radical ...
Malik, 57, is accused of establishing the 'cash cow' firm alongside a pharmacist, a registered scientist and his own former ...
The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...
A pharmacist, a registered scientist and his own former office manager are among the people accused of running a fraudulent Covid-19 testing ...
A New Era in the Treatment of Muscle Invasive Bladder Cancer. Discussant of LBA2 - Perioperative (Periop) Enfortumab Vedotin ...
Study identifies factors behind false negatives in mammograms, including race, breast density, history, and facility type, to improve diagnosis.
The immune system has a tough job: When a tiny virus invades one of our cells, that cell must detect it and, within minutes, ...
Ajertil, A., Jirari Rim, M’Benga. L.-J.K. and El Quessar, A. (2025) Severe and Rare Cerebrovascular Involvement in Systemic Lupus Erythematosus: Case Report and Literature Review. Open Access Library ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback